Recent developments in gastroesophageal mesenchymal tumours

Area of Science:

• Gastroenterology
• Oncology
• Pathology

Background:

• The classification of gastroesophageal mesenchymal tumors has undergone significant evolution over the past 25 years.
• Gastrointestinal stromal tumors (GIST) have transitioned from a general category to a precisely defined entity with detailed genetic subclassification.

Purpose of the Study:

• To review recent advancements in the classification, molecular genetics, and tumor biology of key gastroesophageal mesenchymal tumors.
• To highlight the impact of genetic subclassification on precision medicine approaches for these neoplasms.

Main Methods:

• Review of recent literature on gastroesophageal mesenchymal tumors.
• Focus on developments in classification and molecular genetics.
• Analysis of tumor biology and clinical presentations.

Main Results:

• Gastrointestinal stromal tumors (GIST) are now precisely classified based on genetic subtypes, enabling tailored treatments.
• Molecular data has clarified the nature of esophageal mesenchymal tumors, identifying 'giant fibrovascular polyps' as well-differentiated liposarcoma.
• Recent developments impact the understanding of granular cell tumors, 'giant fibrovascular polyps'/well-differentiated liposarcoma, plexiform fibromyxoma, and gastroblastoma.

Conclusions:

• Genetic subclassification has revolutionized the approach to gastroesophageal mesenchymal tumors, particularly GIST, ushering in an era of precision medicine.
• Improved understanding of molecular genetics and tumor biology is crucial for accurate diagnosis and optimized therapeutic strategies.